- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Mo | FDA delivers de novo clearances to two novel antibacterial implant coatings | ||
| Mo | Butterfly Network expands maternal ultrasound efforts across Africa | ||
| Mo | Regeneron builds new venture arm with $500M commitment to invest in biotech and beyond | ||
| Mo | Pulmocide exits OPERA with phase 2 evidence of antifungal safety and efficacy | ||
| Mo | Neumora's schizophrenia drug faces FDA hold over convulsions in rabbits | ||
| Mo | MaaT, eyeing 2026 launch for microbiome therapy, posts 18-month data in aGvHD | ||
| 12.04. | Roche picks up Prenosis' newly cleared sepsis AI tool for distribution | ||
| 12.04. | Genentech axes Adaptimmune cell therapy deal as it presses ahead with staff cuts | ||
| 12.04. | Portage Biotech hints at potential closure as it halts programs, hunts for strategic options | ||
| 12.04. | Illumina gets go-ahead from European Commission to part ways with Grail | ||
| 12.04. | Enlivex defends sepsis data that sank stock, shifting focus from mortality to subgroup analysis | ||
| 12.04. | Novartis may have bought MorphoSys, but it really only had eyes for BET inhibitor pelabresib: filing | ||
| 11.04. | Peak Rock Capital takes a bite out of Steris with $787M dental business deal | ||
| 11.04. | Alzheimer's blood test from Roche & Eli Lilly nabs FDA breakthrough tag | ||
| 11.04. | Double autoimmune acquisitions as Century, Eliem each pick up peers | ||
| 11.04. | Novartis pays $150M for Arvinas' phase 3-ready prostate cancer protein degrader | ||
| 11.04. | AACR: Verastem, Quanta and Frontier demonstrate KRAS inhibitors' potential in preclinical data | ||
| 10.04. | Nearly a week after pulling Relyvrio, Amylyx to engage regulators about the drug's path in another rare disease | ||
| 10.04. | Philips plots return to US sleep apnea market after final consent decree in CPAP recall | ||
| 10.04. | AACR: To bring CAR-T to solid tumors, Poseida thinks we need to boost conditioning therapy | ||
| 10.04. | AACR: Synthekine hopes new IL-2 will be the high-alpha in a beta class | ||
| 10.04. | Bristol Myers-backed TORL secures $158M to march army of ADCs through clinic | ||
| 09.04. | Alcanza acquires Innovation Medical Research Center location outside Miami | ||
| 09.04. | MMI's Symani microsurgery robot secures de novo clearance from FDA | ||
| 09.04. | ACC: Medtronic heart valve shows benefits in head-to-head TAVR study focused on women |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
